Bone Biologics (BBLG) Debt Ratio (2012 - 2019)

Bone Biologics (BBLG) has 8 years of Debt Ratio data on file, last reported at 367.21 in Q4 2019.

• Debt Ratio for Q4 2019 came in at 367.21, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was 367.21 (changed N/A YoY), and the FY2019 annual result was 367.21, changed N/A from the prior year.
• Debt Ratio climbed to 367.21 in Q4 2019 per BBLG's latest filing, from 3.83 in the prior quarter.
• Over five years, Debt Ratio peaked at 367.21 in Q4 2019 and troughed at 1.17 in Q1 2015.
• A 5-year average of 32.52 and a median of 10.71 in 2017 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2015 and 2018: Debt Ratio soared 1029.52% in 2015, then sank 68.22% in 2018.
• A 5-year view of Debt Ratio shows it stood at 4.58 in 2015, then surged by 172.96% to 12.5 in 2016, then fell by 17.24% to 10.34 in 2017, then sank by 62.98% to 3.83 in 2018, then soared by 9489.51% to 367.21 in 2019.
• Business Quant data shows BBLG's Debt Ratio at 367.21 in Q4 2019, 3.83 in Q3 2018, and 22.67 in Q2 2018.